연구동향 분석

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial

Hyeong Ho Jo Eun Young Kim Jin Tae Jung Joong Goo Kwon Eun Soo Kim Hyun Seok Lee Yoo Jin Lee Kyeong Ok Kim Byung Ik Jang 2022년

논문상세정보
인용/피인용
' Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Diagnosis
  • Intestinal tuberculosis
  • Therapeutic anti-tubercular trial
  • fecal calprotectin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
578 0

0.0%

' Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial' 의 참고문헌

  • 장결핵 진단 가이드라인
    김유선 [2009]
  • Utility of in vitro interferon-γ release assay in differential diagnosis between intestinal tuberculosis and Crohn’s disease
    Lei Y [2013]
  • The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
    이양운 [2019]
  • The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn’s disease in China
    Li Y [2012]
  • The intra-individual variability of faecal calprotectin : a prospective study in patients with active ulcerative colitis
    Lasson A [2015]
  • Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis
    Seo H [2017]
  • Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy
    Sharma V [2021]
  • Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
    KonikoffMR [2006]
  • Review article : biological activity markers in inflammatory bowel disease
    Desai D [2007]
  • Present status and strategy of NSAIDs-induced small bowel injury
    Higuchi K [2009]
  • Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn’s disease
    Jin XJ [2010]
  • From bench to bedside : fecal calprotectin in inflammatory bowel diseases clinical setting
    Mumolo MG [2018]
  • Fluorescent quantitative PCR of Mycobacterium tuberculosis for differentiating intestinal tuberculosis from Crohn’s disease
    Fei BY [2014]
  • Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn’s disease from intestinal tuberculosis
    Ramadass B [2010]
  • Fecal Biomarkers in Inflammatory Bowel Disease
    이강문 [2013]
  • Faecal calprotectin
  • Factors associated with false negative interferon-γ release assay results in patients with tuberculosis : a systematic review with meta-analysis
    Yamasue M [2020]
  • Effectiveness of interferon-gamma release assays for differentiating intestinal tuberculosis from Crohn’s disease : a meta-analysis
    Chen W [2013]
  • Distinguishing Crohn’s disease from intestinal tuberculosis--a prospective study
    Dutta AK [2011]
  • Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent
  • Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis
    Makharia GK [2010]
  • Asia Pacific Consensus Statements on Crohn’s disease. Part 1 : definition, diagnosis, and epidemiology : (asia pacific Crohn’s disease consensus--Part 1)
    Ooi CJ [2016]